• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND RESOLUTE ONYX RX; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND RESOLUTE ONYX RX; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Catalog Number RONYX30008X
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Death (1802); Myocardial Infarction (1969); Occlusion (1984); Thrombus (2101); Cardiogenic Shock (2262)
Event Date 01/01/2019
Event Type  Death  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
During the index procedure two resolute onyx stents were implanted into the cx and one resolute onyx stent was implanted into the lcma.Approximately 5 months post index procedure, the patient suffered cardiogenic shock.Myocardial infarction of the target vessels- lcx and lm was also reported.The patient was treated with ptca and stenting with two resolute onyx implanted in the cx and lcma but passed away.The patient's death was classified as non sudden cardiac death.The investigator assessed the event as possibly related to the device and unlikely to be related to anti-platelet medication.Cec adjudicated non-q-wave mi (target vessel), 3 rd udmi spontaneous, prox cx, lcma.Cec adjudicated death, cardiac.Cec adjudicated tlr-pci as clinically driven of lcma and cx, reason for revascularization: clinical judgement.Cec adjudicated late stent thrombosis, arc definite- lcma & cx, due to occlusion of left main/lcx in setting of acute mi stent thrombosis.Cec also adjudicated thrombotic occlusion of the study stent did not occur subsequent to repeat pci of the target lesion and the stent thrombosis is not related to a non study stent or to non target lesion.
 
Manufacturer Narrative
The investigator assessed the mi as possibly related to the device and not related to anti-platelet medication.Mi was due to in-stent re stenosis.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RESOLUTE ONYX RX
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key8523153
MDR Text Key142338687
Report Number9612164-2019-01384
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeSZ
PMA/PMN Number
P160043
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 07/31/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/23/2020
Device Catalogue NumberRONYX30008X
Device Lot Number0009342071
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/23/2019
Initial Date FDA Received04/17/2019
Supplement Dates Manufacturer Received07/04/2019
Supplement Dates FDA Received07/31/2019
Date Device Manufactured09/24/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death; Hospitalization; Required Intervention;
Patient Age84 YR
Patient Weight79
-
-